Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Apr;48(1):213–217.

An islet cell antibody negative form of insulin-dependent diabetes mellitus (IDD) associated with HLA antigens A9 and Bw16.

A Mustonen, J Ilonen, H K Akerblom, A Tiilikainen
PMCID: PMC1536579  PMID: 7044630

Abstract

One hundred and sixty-six unrelated children and adolescents having growth-onset, insulin-dependent diabetes mellitus (IDD) were studied for pancreatic-cytoplasmic islet cell antibodies (ICA) at various times from the diagnosis of the disease. A strong association between HLA antigens A9 and Bw16 and an absence of ICA early in the course of disease was seen. On the other hand B8/Dw3 or B15/Dw4 antigens were not significantly associated with the occurrence of ICA although both these antigens are greatly increased among pediatric IDD patients in northern Finland. The finding of the association of the HLA antigens A9 and Bw16 with ICA-negativity contributes to the evidence for the heterogeneity in the genetic susceptibility to IDD.

Full text

PDF
213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bottazzo G. F., Doniach D. [Pancreatic autoimmunity and HLA antigens]. Lancet. 1976 Oct 9;2(7989):800–800. doi: 10.1016/s0140-6736(76)90631-0. [DOI] [PubMed] [Google Scholar]
  2. Bottazzo G. F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974 Nov 30;2(7892):1279–1283. doi: 10.1016/s0140-6736(74)90140-8. [DOI] [PubMed] [Google Scholar]
  3. Crossley J. R., James A. G., Elliot R. B., Berryman C. C., Edgar B. W. Residual beta-cell function and islet cell antibodies in diabetic children. Pediatr Res. 1981 Jan;15(1):62–65. doi: 10.1203/00006450-198101000-00015. [DOI] [PubMed] [Google Scholar]
  4. Cudworth A. G., Woodrow J. C. HL-A system and diabetes mellitus. Diabetes. 1975 Apr;24(4):345–349. doi: 10.2337/diab.24.4.345. [DOI] [PubMed] [Google Scholar]
  5. Farquhar J. W. Juvenile diabetes mellitus: possibility of prevention. Arch Dis Child. 1979 Aug;54(8):569–580. doi: 10.1136/adc.54.8.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ilonen J., Herva E., Tiilikainen A., Akerblom H. K., Koivukangas T., Kouvalainen K. HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens. 1978 Feb;11(2):144–146. doi: 10.1111/j.1399-0039.1978.tb01239.x. [DOI] [PubMed] [Google Scholar]
  7. Ilonen J., Herva E., Tiilikainen A., Akerblom H. K., Mustonen A., Koivukangas T., Kouvalainen K. HLA genetics of insulin-dependent juvenile-onset diabetes mellitus in northern Finland. Tissue Antigens. 1980 Apr;15(4):381–388. doi: 10.1111/j.1399-0039.1980.tb00199.x. [DOI] [PubMed] [Google Scholar]
  8. Ilonen J., Mustonen A., Akerblom H. K., Huttunen N. P. Complement-fixing islet-cell antibodies before and after onset of insulin-dependent diabetes. Lancet. 1980 Oct 11;2(8198):805–805. doi: 10.1016/s0140-6736(80)90422-5. [DOI] [PubMed] [Google Scholar]
  9. Irvine W. J. Classification of idiopathic diabetes. Lancet. 1977 Mar 19;1(8012):638–642. doi: 10.1016/s0140-6736(77)92071-2. [DOI] [PubMed] [Google Scholar]
  10. Irvine W. J., Gray R. S., McCallum C. J. Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes. Lancet. 1976 Nov 20;2(7995):1097–1102. doi: 10.1016/s0140-6736(76)91084-9. [DOI] [PubMed] [Google Scholar]
  11. Lendrum R., Walker G., Gamble D. R. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet. 1975 Apr 19;1(7912):880–882. doi: 10.1016/s0140-6736(75)91683-9. [DOI] [PubMed] [Google Scholar]
  12. Morris P. J., Irvine W. J., Gray R. S., Duncan L. J., Vaughan H., McCallum F. J., Campbell C. J., Farquhar J. W. HLA and pancreatic islet cell antibodies in diabetes. Lancet. 1976 Sep 25;2(7987):652–653. doi: 10.1016/s0140-6736(76)92464-8. [DOI] [PubMed] [Google Scholar]
  13. Nerup J., Platz P., Andersen O. O., Christy M., Lyngsoe J., Poulsen J. E., Ryder L. P., Nielsen L. S., Thomsen M., Svejgaard A. HL-A antigens and diabetes mellitus. Lancet. 1974 Oct 12;2(7885):864–866. doi: 10.1016/s0140-6736(74)91201-x. [DOI] [PubMed] [Google Scholar]
  14. Rotter J. I., Rimoin D. L. The genetics of the glucose intolerance disorders. Am J Med. 1981 Jan;70(1):116–126. doi: 10.1016/0002-9343(81)90418-6. [DOI] [PubMed] [Google Scholar]
  15. Tattersall R., Pyke D., Nerup J. Genetic patterns in diabetes mellitus. Hum Pathol. 1980 May;11(3):273–283. doi: 10.1016/s0046-8177(80)80009-8. [DOI] [PubMed] [Google Scholar]
  16. Thomsen M., Platz P., Andersen O. O., Christy M., Lyngsøoe, Nerup J., Rasmussen K., Ryder L. P., Nielsen L. S., Svejgaard A. MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev. 1975;22:125–147. doi: 10.1111/j.1600-065x.1975.tb01555.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES